Predictive Oncology (FRA:S1K) Ending Cash Position : €4.95 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology Ending Cash Position?

Predictive Oncology's Ending Cash Position for the quarter that ended in Jun. 2024 was €4.95 Mil.

Predictive Oncology's quarterly Ending Cash Position declined from Dec. 2023 (€8.00 Mil) to Mar. 2024 (€4.78 Mil) but then increased from Mar. 2024 (€4.78 Mil) to Jun. 2024 (€4.95 Mil).

Predictive Oncology's annual Ending Cash Position declined from Dec. 2021 (€24.96 Mil) to Dec. 2022 (€20.84 Mil) and declined from Dec. 2022 (€20.84 Mil) to Dec. 2023 (€8.00 Mil).

Predictive Oncology Ending Cash Position Historical Data

The historical data trend for Predictive Oncology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Ending Cash Position Chart

Predictive Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.14

0.56

24.96

20.84

8.00

Predictive Oncology Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															13.63	11.16	8.00	4.78	4.95

Predictive Oncology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Predictive Oncology's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20.238	+	-12.234
	=	8.00

Predictive Oncology's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.828	+	0.125
	=	4.95

Predictive Oncology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Predictive Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

POAI:USA

Address

No.91 43rd Street, Suite 110, Pittsburgh, PA, USA, 55121

Website

https://www.predictive-oncology.com

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Predictive Oncology Headlines

No Headlines